SAUNDRA L PELLETIER Insider Trading $NEOT Evofem Biosciences, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SAUNDRA L PELLETIER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SAUNDRA L PELLETIER. SAUNDRA L PELLETIER is Director in Tracon Pharmaceuticals, Inc. ($TCON) and Chief Executive Officer in Evofem Biosciences, Inc. ($NEOT).
SAUNDRA L PELLETIER in Evofem Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SAUNDRA L PELLETIER: Chief Executive Officer
Holdings: 906,137 shares
Current Value: $1,540,433
Latest Transaction: Mar 09 2021
$NEOT Market Capitalization: $26.27M
$NEOT Previous Close: $1.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of SAUNDRA L PELLETIER in Evofem Biosciences, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 09 2021 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Buy | P | 2.28 | 45,249 | 103,168 | 906,137 | 860.9 K to 906.1 K (+5.26 %) |
| Feb 03 2021 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Option Exercise | A | 3.25 | 700,000 | 2,275,000 | 700,000 | |
| Feb 03 2021 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Grant | A | 0.00 | 500,000 | 0 | 860,888 | 360.9 K to 860.9 K (+138.55 %) |
| Sep 10 2020 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Sell | S | 3.26 | 122,500 | 399,350 | 360,888 | 483.4 K to 360.9 K (-25.34 %) |
| Jun 08 2020 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Payment of Exercise | F | 3.31 | 85,620 | 283,402 | 479,085 | 564.7 K to 479.1 K (-15.16 %) |
| May 26 2020 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Payment of Exercise | F | 4.99 | 84,525 | 421,780 | 564,705 | 649.2 K to 564.7 K (-13.02 %) |
| May 08 2020 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Payment of Exercise | F | 5.24 | 16,905 | 88,582 | 649,230 | 666.1 K to 649.2 K (-2.54 %) |
| Feb 07 2020 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Option Exercise | A | 4.87 | 300,000 | 1,461,000 | 300,000 | |
| Feb 07 2020 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Grant | A | 0.00 | 300,000 | 0 | 666,135 | 366.1 K to 666.1 K (+81.94 %) |
| Feb 07 2020 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Grant | A | 5.21 | 3,846 | 20,038 | 366,135 | 362.3 K to 366.1 K (+1.06 %) |
| Jan 15 2020 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Sell | S | 6.00 | 3,295 | 19,770 | 362,289 | 365.6 K to 362.3 K (-0.90 %) |
| Jan 06 2020 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Sell | S | 6.05 | 6,705 | 40,565 | 365,584 | 372.3 K to 365.6 K (-1.80 %) |
| Dec 04 2019 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Sell | S | 7.30 | 20,000 | 146,000 | 372,289 | 392.3 K to 372.3 K (-5.10 %) |
| Nov 26 2019 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Payment of Exercise | F | 6.22 | 22,387 | 139,247 | 392,289 | 414.7 K to 392.3 K (-5.40 %) |
| Nov 21 2019 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Sell | S | 6.01 | 10,000 | 60,100 | 414,676 | 424.7 K to 414.7 K (-2.35 %) |
| Nov 21 2019 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Payment of Exercise | F | 5.74 | 22,657 | 130,051 | 424,676 | 447.3 K to 424.7 K (-5.06 %) |
| Aug 26 2019 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Payment of Exercise | F | 5.13 | 4,923 | 25,255 | 447,333 | 452.3 K to 447.3 K (-1.09 %) |
| Jun 12 2019 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Payment of Exercise | F | 6.36 | 35,826 | 227,853 | 452,256 | 488.1 K to 452.3 K (-7.34 %) |
| Apr 03 2019 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Payment of Exercise | F | 3.55 | 3,731 | 13,245 | 488,082 | 491.8 K to 488.1 K (-0.76 %) |
| Aug 13 2018 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Buy | P | 2.11 | 10,000 | 21,100 | 341,813 | 331.8 K to 341.8 K (+3.01 %) |
| Jul 03 2018 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Payment of Exercise | F | 2.46 | 493,187 | 1,213,240 | 331,813 | 825 K to 331.8 K (-59.78 %) |
| Jul 03 2018 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Grant | A | 0.00 | 825,000 | 0 | 825,000 | 0 to 825 K |
| Mar 14 2018 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Option Exercise | A | 7.29 | 825,000 | 6,014,250 | 825,000 | |
| Jan 18 2018 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Option Exercise | A | 79.87 | 6,719 | 536,647 | 6,719 | |
| Jan 18 2018 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Option Exercise | A | 46.36 | 9,994 | 463,322 | 9,994 | |
| Jan 18 2018 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Option Exercise | A | 46.36 | 12,833 | 594,938 | 12,833 | |
| Jan 18 2018 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Option Exercise | A | 46.36 | 19,249 | 892,384 | 19,249 |
Page: 1